Latest tumor Stories
Aldoxorubicin Has Now Shown Two Complete Responses, In Addition to Tumor Shrinkage, Prolonged Stable Disease, and Favorable Tolerability in Patients LOS ANGELES, May 21, 2015 /PRNewswire/
Unusually broad range of tumors treated, other benefits seen in first year-plus of operation SAN DIEGO, May 20, 2015 /PRNewswire/ -- The nation's first and only proton therapy center
MADRID, May 14, 2015 /PRNewswire/ -- - Compelling clinical activity of PM1183 in second line, achieving 67% response rate and a progression-free
Research Demonstrates Clinical Utility of Caris Molecular Intelligence and Advances Molecular Understanding of Cancer to Enable the Delivery of Precision Medicine IRVING, Texas, May 14, 2015
Abstracts: 5034, TPS5082, 5063, TPS1104, 3558, 3560, 6015, TPS5080 WHIPPANY, N.J., May 13, 2015 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc.
THOUSAND OAKS, Calif., May 13, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that data at the 51(st) Annual Meeting of the American Society of Clinical Oncology (ASCO) will showcase the
Children's Hospital of Orange County Designated a Caris Center of Excellence and Dr.
Role created to expand company's continued commitment to quality and clinical impact of cell-free tumor DNA REDWOOD CITY, Calif., May 7, 2015 /PRNewswire/ --
Combination Clinical Trial Data Showing Impressive Activity in Bone Cancer and Other Sarcomas LOS ANGELES, May 4, 2015 /PRNewswire/ -- CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical
- A handkerchief.
- In general, any miraculous portrait of Christ.